UK TRADING UPDATE SUMMARY: Polarean And Amryt Get US FDA Boost
Wed, 23rd Dec 2020 19:50
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News:
Polarean Imaging PLC - medical imaging products developer - Says US Food & Drug Administration approves company s new drug application. FDA acceptance for the filing of Polarean s NDA represents another important step forward for the Company s platform. If approved, Polarean s drug-device technology could provide a new diagnostic option for patients with pulmonary disease, Chief Executive Officer Richard Hullihen says. Polarean adds that Chief Operating Officer Ken West plans to retire as employee of company but to stay involved as a consultant before transitioning to non-executive role.